ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,186, issued on Jan. 28, was assigned to FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (Bad Homburg, Great Britain).
"Extracorporeal blood treatment device" was invented by Lars Offermanns (Butzbach, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to an extracorporeal blood treatment device (1), preferably a hemodialysis device, hemofiltration device, or hemodiafiltration device, comprising a fluidic system (2) having a connection point (20) for adding substances, a detection arrangement (4) for detecting a flow of a substance at the connection point (20), wherein the detection arrangement is configured to generate a f...